EXCL Stock Overview
A development stage company, focuses on providing a range of health advisory and tour services to legal entities and individuals. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Excellerant, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0002 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -99.50% |
| 3 Year Change | -100.00% |
| 5 Year Change | n/a |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| EXCL | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | 1.3% | 0.6% |
| 1Y | -99.5% | -9.7% | 23.7% |
Return vs Industry: EXCL underperformed the US Healthcare industry which returned 11.5% over the past year.
Return vs Market: EXCL underperformed the US Market which returned 25.6% over the past year.
Price Volatility
| EXCL volatility | |
|---|---|
| EXCL Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.6% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 17.5% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: EXCL has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine EXCL's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | n/a | Roman Kopinski | excellerant.vc |
Excellerant, Inc., a development stage company, focuses on providing a range of health advisory and tour services to legal entities and individuals. The company intends to offer consulting services in the field of traditional and alternative medicine, and medical technologies; for customers to choose a clinic for treatment, as well as arrange the itinerary by building a route, which includes clinics, hospitals, and other medical institutions; and providing guide services to potential clients. Further, it provides information related to transportation and medical institutions.
Excellerant, Inc. Fundamentals Summary
| EXCL fundamental statistics | |
|---|---|
| Market cap | US$5.00 |
| Earnings (TTM) | -US$13.80k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs EXCL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EXCL income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$13.80k |
| Earnings | -US$13.80k |
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did EXCL perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/08/20 14:01 |
| End of Day Share Price | 2024/05/23 00:00 |
| Earnings | 2021/09/30 |
| Annual Earnings | 2021/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Excellerant, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|